Skip to main navigation Skip to search Skip to main content

Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation

  • Catholic Univ. of Korea Coll. Med.
  • Green Cross Genome Corporation

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations
Original languageEnglish
Pages (from-to)e43-e44
JournalEuropean Journal of Neurology
Volume24
Issue number7
DOIs
StatePublished - Jul 2017

Keywords

  • episodic ataxia type 2
  • levetiracetam

Cite this